MS brain health quality standards: a survey on the reality in clinical practice in Germany
Abstract Background The quality of treatment is especially critical in the context of complex and chronic diseases such as multiple sclerosis (MS). The Brain Health Initiative, an independent international consortium of neurologists, reached a consensus on time-based quality standards prioritizing b...
Saved in:
| Main Authors: | Isabel Voigt, Katja Akgün, Hernan Inojosa, Judith Haas, Herbert Temmes, Sven G. Meuth, Gavin Giovannoni, Tjalf Ziemssen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Neurological Research and Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42466-024-00333-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany
by: Mathias Buttmann, et al.
Published: (2025-05-01) -
Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab
by: Tjalf Ziemssen, et al.
Published: (2024-12-01) -
Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs
by: Hannah Solchenberger, et al.
Published: (2025-02-01) -
Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC)
by: Tjalf Ziemssen, et al.
Published: (2023-08-01) -
Variations in neuronal cytoskeletal integrity affect directed communication in distributed networks during inhibitory control
by: Julia Elmers, et al.
Published: (2025-03-01)